Expression of the tumor-rejection antigen SART1 in brain tumors.


We have reported a tumor-rejection antigen, SART1(259), possessing tumor epitopes capable of inducing cytotoxic T lymphocytes (CTLs) in epithelial-cancer patients. This study investigated the expression of SART1(259) antigen in brain tumors, to explore for a potential molecule for use in specific immunotherapy of patients with brain tumors. The SART1(259… (More)


Cite this paper

@article{Imaizumi1999ExpressionOT, title={Expression of the tumor-rejection antigen SART1 in brain tumors.}, author={Tadaatsu Imaizumi and Terukazu Kuramoto and Kayoko Matsunaga and Satoki Shichijo and Sachiko Yutani and Masato Shigemori and Kazuya Oizumi and K Itoh}, journal={International journal of cancer}, year={1999}, volume={83 6}, pages={760-4} }